仁和药业
(000650)
| 流通市值：68.30亿 | | | 总市值：71.82亿 |
| 流通股本：13.31亿 | | | 总股本：14.00亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 2,791,652,026.3 | 2,090,941,027.03 | 1,129,224,010.41 | 3,536,422,014.45 |
| 营业总成本 | 2,257,169,543.37 | 1,670,769,053.24 | 892,993,180.85 | 2,913,953,460.09 |
| 其他经营收益 | | | | |
| 营业利润 | 601,176,315.21 | 464,017,658.18 | 243,032,389.65 | 665,212,074.03 |
| 利润总额 | 602,788,899.92 | 464,868,800.17 | 242,906,872.66 | 664,896,992.99 |
| 净利润 | 457,076,674.29 | 355,382,564.49 | 178,229,990.11 | 487,656,749.45 |
| 每股收益 | | | | |
| 其他综合收益 | -45,889.74 | -35,537.68 | -20,777.29 | -5,987.04 |
| 综合收益总额 | 457,030,784.55 | 355,347,026.81 | 178,209,212.82 | 487,650,762.41 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 5,035,870,744.17 | 5,236,837,784.85 | 5,159,388,359.69 | 4,944,357,276.78 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,734,434,078.63 | 2,919,719,240.04 | 2,774,547,730.86 | 2,790,761,199.83 |
| 资产总计 | 7,770,304,822.8 | 8,156,557,024.89 | 7,933,936,090.55 | 7,735,118,476.61 |
| 流动负债: | | | | |
| 流动负债合计 | 654,579,603.51 | 928,523,101.79 | 784,542,455.45 | 762,756,946.63 |
| 非流动负债: | | | | |
| 非流动负债合计 | 36,421,093.45 | 37,703,974.08 | 39,328,256.11 | 40,505,363.81 |
| 负债合计 | 691,000,696.96 | 966,227,075.87 | 823,870,711.56 | 803,262,310.44 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 6,380,058,723.62 | 6,512,636,487.51 | 6,455,925,808.08 | 6,315,571,807.63 |
| 股东权益合计 | 7,079,304,125.84 | 7,190,329,949.02 | 7,110,065,378.99 | 6,931,856,166.17 |
| 负债和股东权益合计 | 7,770,304,822.8 | 8,156,557,024.89 | 7,933,936,090.55 | 7,735,118,476.61 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,982,496,931.12 | 2,182,069,871.32 | 905,244,506.52 | 4,346,362,181.42 |
| 经营活动现金流出小计 | 2,564,476,168.93 | 1,609,645,691.83 | 780,690,848.9 | 3,495,050,181.52 |
| 经营活动产生的现金流量净额 | 418,020,762.19 | 572,424,179.49 | 124,553,657.62 | 851,311,999.9 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 8,418,984,049.53 | 5,350,753,255.63 | 2,868,343,038.85 | 11,949,742,452.04 |
| 投资活动现金流出小计 | 10,213,697,265.05 | 7,265,000,717.3 | 4,756,172,447.31 | 12,048,027,596.98 |
| 投资活动产生的现金流量净额 | -1,794,713,215.52 | -1,914,247,461.67 | -1,887,829,408.46 | -98,285,144.94 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 2,433,137.15 | - | 0 | 2,405,000 |
| 筹资活动现金流出小计 | 312,106,924.78 | 96,622,551.38 | 0 | 307,025,198.66 |
| 筹资活动产生的现金流量净额 | -309,673,787.63 | -96,622,551.38 | 0 | -304,620,198.66 |
| 汇率变动对现金及现金等价物的影响 | -45,889.74 | -35,537.68 | -20,777.29 | -9,950.5 |
| 现金及现金等价物净增加额 | -1,686,412,130.7 | -1,438,481,371.24 | -1,763,296,528.13 | 448,396,705.8 |
| 期末现金及现金等价物余额 | 1,087,549,247.84 | 1,335,480,007.3 | 1,010,664,850.41 | 2,773,961,378.54 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -1,438,481,371.24 | - | 448,396,705.8 |